Oral dexketoprofen for pain treatment during diagnostic hysteroscopy in postmenopausal women

F Mercorio, Raffaella De Simone, Paola Landi, Anna Sarchianaki, Giovanni Tessitore, Carmine Nappi
In: Maturitas · 2002 · vol. 43(4) , pp. 277–281 · doi:10.1016/s0378-5122(02)00186-x · PMID:12468136 · W2155332721
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study evaluated the efficacy of oral dexketoprofen in managing pain experienced by postmenopausal women undergoing diagnostic hysteroscopy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo assess the efficacy of dexketoprofen (DEX) in reducing pain at different stages of the hysteroscopic procedure in comparison with local anaesthesia in menopausal women.MethodsMenopausal patients affected by uterine bleeding submitted to diagnostic hysteroscopy, were randomised to receive either 25 mg DEX tablet (n = 148) or intracervical injection of 5 ml mepivacaine 2% (n = 150). Pain suffered during the procedure itself and 30, 60, 120 min after, was scored on the 11 point Visual Analogic Scale, recorded and analysed.ResultsNo statistical difference were noted during the procedure itself in both groups of treatment. Patients treated with DEX has significantly less postoperative pain.ConclusionsDEX is not superior to mepivacaine in reducing the discomfort of the procedure but does significantly reduce postoperative pain.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

References (22)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-14T06:54:16.401154+00:00
License: CC0 · commercial use OK